Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Wiener Medizinische Wochenschrift (1946)|January 1, 1994
Klinefelter's syndrome as a model for skin changes in venous insufficiencyJ C Veraart, K Hamulyak, H A NeumannThe British Journal of Dermatology|May 1, 1994
Increased plasma activity of plasminogen activator inhibitor 1 (PAI-1) in two patients with Klinefelter's syndrome complicated by leg ulcersJ C Veraart, K Hamulyak, H A Neumann, et al.Diabetes|January 1, 1995
Tissue factor pathway inhibitor activity in patients with IDDMP B Leurs, R van Oerle, K Hamulyak, et al.Thrombosis and Haemostasis|November 1, 2000
The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patientsI M Keularts, K Hamulyak, H C Hemker, et al.Thrombosis and Haemostasis|March 1, 1997
Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitusP B Leurs, R van Oerle, B H Wolffenbuttel, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 10, 2003
Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuriaP B Leurs, R van Oerle, K Hamulyak, et al.European Journal of Haematology|August 1, 1997
Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitorJ J Michiels, K Hamulyak, H K Nieuwenhuis, et al.Archives of Dermatology|January 29, 1999
The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiencyM B Maessen-Visch, K Hamulyak, D J Tazelaar, et al.The Cochrane Database of Systematic Reviews|February 20, 2004
Non-pharmaceutical measures for prevention of post-thrombotic syndromeD N Kolbach, M W C Sandbrink, K Hamulyak, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 21, 2014
Concentrated citrate locking in order to reduce the long-term complications of central venous catheters: a randomized controlled trial in patients with hematological malignanciesR S Boersma, K S Jie, A C Voogd, et al.Pageof 2